Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice
about
HPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and TreatmentLocal Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumorHuman papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells.Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer.Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity.Immunotherapeutic strategies for bladder cancer.Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases.Moving forward with human papillomavirus immunotherapies.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Chronic Myelocytic Leukemia (CML) Patient-Derived Dendritic Cells Transfected with Autologous Total RNA Induces CML-Specific Cytotoxicity.Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model.Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.Tumor Resident Memory T Cells: New Players in Immune Surveillance and Therapy
P2860
Q34290170-92C7B8BF-4F1B-44EA-977E-4CA3671FA438Q35798992-E4CE58DA-C7D3-46B8-B94D-5E8AE3A624EEQ36350381-990E1B5F-78CC-4C0B-9B77-05E07C3E7114Q36643691-45103482-3F97-4EDD-A07C-C7D20AA3DE16Q36711018-6BD25FF0-1D88-41A2-ADFA-B704C2922308Q36757129-6A19C85D-96C8-4CC1-B741-1CF35D4167EFQ36977628-A42BC65B-C739-4BEF-AF85-FDC8361753AFQ36978334-077C90A5-5F0C-4DD5-8FCC-FB0336494085Q37134623-1E85D432-950E-41A9-ADC7-F3B18B50BDD3Q37135023-3DD53AE4-6690-4C72-B6F8-29CEA14FD765Q37473299-0312036B-70DE-4E75-A90C-F18851617CDDQ38370782-C143E130-0340-4EF5-BD77-D99277251E0CQ47146006-8EC145F4-BDD9-4BEB-B1CC-AC0D6FB77787Q47224779-9D7BDBE7-249F-4A77-BD8E-D7BCCB4240B1Q55003290-5A85CFBE-672B-4F54-A50C-2B64495169E4Q58750149-0E3FFBAF-E8F5-40A0-B0D3-8C692B618227
P2860
Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@ast
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@en
type
label
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@ast
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@en
prefLabel
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@ast
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@en
P2093
P2860
P356
P1433
P1476
Intravaginal TLR agonists incr ...... nital-tumor regression in mice
@en
P2093
J T Schiller
L Decrausaz
P Jichlinski
S Domingos-Pereira
P2860
P2888
P304
P356
10.1038/MI.2012.83
P577
2012-09-12T00:00:00Z